<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Why DexCom (DXCM) Shares Are Sliding Today — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why DexCom (DXCM) Shares Are Sliding Today</h2>
    <div class="badge">2025-09-08T15:45:57+00:00</div>
    <ul>
      <li>DexCom is up 0.8% since the beginning of the year, but at $79.17 per share, it is still trading 12.8% below its 52-week high of $90.75 from February 2025.</li>
<li>In addition to the downgrade, Oppenheimer also removed its $102 price target for the medical device maker.</li>
<li>What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.</li>
<li>The previous big move we wrote about was 4 days ago when the stock gained 3.3% on the news that company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference.</li>
<li>Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $813.64.</li>
<li>Shares of medical device company DexCom (NASDAQ:DXCM) fell 2% in the morning session after Oppenheimer downgraded the stock to Perform from a previous Outperform rating.</li>
<li>What Happened?</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Why DexCom (DXCM) Shares Are Sliding Today\n• DexCom is up 0.8% since the beginning of the year, but at $79.17 per share, it is still trading 12.8% below its 52-week high of $90.75 from February 2025.\n• In addition to the downgrade, Oppenheimer also removed its $102 price target for the medical device maker.\n• What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.\n• The previous big move we wrote about was 4 days ago when the stock gained 3.3% on the news that company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference.\n• Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $813.64.\n• Shares of medical device company DexCom (NASDAQ:DXCM) fell 2% in the morning session after Oppenheimer downgraded the stock to Perform from a previous Outperform rating.\n• What Happened?" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/why-dexcom-dxcm-shares-sliding-154557286.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>